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Letter to the Editor:
When Do Antibiotics Induce "Resistance"?
o the Editor:
McDuffie et al. have reported 4 cases of En-
terobacteriaceae chorioamnionitis occurring in gravi-
das who received ampicillin prophylaxis for prema-
ture rupture of the fetal membranes and group-B
streptococcus carriage. Three of the isolates were am-
picillin-resistant Escherichia coli. The fourth case was
due to Klebsiella pneumoniae. Two of the resultant
neonates died with fulminant perinatal septicemia.
The rationale for the publication of their manuscript
was the contention that these were examples of "ad-
verse perinatal outcomes due to selection or over-
growth of resistant organisms resulting from the use
of ampicillin." More recently, Amstey and Gibbs
have written an editorial opinion in which they have
contended that the "favorable pharmacokinetics of
penicillin G and its narrow and specific spectrum
results in diminished potential for selecting more re-
sistant organisms (in comparison to ampicillin)."
INTRINSIC VS. INDUCED RESISTANCE
Induced Resistance
The prolonged use (especially associated with subop-
timal dosing) of an antibiotic can allow the emergence
of a resistant subpopulation of a previously suscepti-
ble strain which then becomes the dominant popula-
tion. An example of this phenomenon is the abuse
of kanamycin during the 1970s in newborn intensive
care units (NICUs), resulting in K.pneumoniae isolates
that were resistant to virtually all the aminoglycosides
available at that time. Another example of induced
resistance is the change in the avidity of the binding
of penicillin to the penicillin-binding proteins of se-
lected strains of Streptococcus pneumoniae.
If induced resistance to ampicillin had occurred
within the discipline of obstetrics and gynecology, its
emergence would have been documented in NICUs.
Virtually every infant suspected of sepsis receives
ampicillin and gentamycin. The medical and nursing
staff in these units would have become vectors for
resistant gram-positive bacteria whose ultimate sum-
mation would have been epidemics of bacteria that
were traditionally susceptible to ampicillin but subse-
quently resistant.
Intrinsic Resistance
If an antibiotic is used against a bacterium whose
spectrum of susceptibility is not encompassed by that
antibiotic, one cannot anticipate having a true biologic
effect. Approximately 35-40% of all current E. coli
isolates are resistant to ampicillin. This resistance is
mediated primarily by the presence of significant
quantities of [3-1actamases within the periplasmic
space. Over 95% of all K. pneumoniae isolates are simi-
larly inherently resistant to ampicillin. When isolated
instances of disease due to Enterobacteriaceae occur
in the face of ampicillin therapy, the probability is
that the same pattern of disease would have been
observed whether ampicillin had been given or not.
Unless one is dealing with a phenomenon such as
anaerobic progression or the use of antibiotics which
have an impact on 30 or 50S ribosomes, noneffective
antibiotics will not alter the progress of monoetio-
logic disease.
Chorioamnionitis is a community-acquired infec-
tion. The bacteria causing this disease are almost
invariably brought into the hospital by the patient
per se. The susceptibility of a given isolate reflects
the susceptibility of the genus in the community. In
an unpublished review (Monif, unpublished data) of
chorioamnionitis and perinatal septicemia dating from
the early 1970s (when the therapy was penicillin and
kanamycin or ampicillin), ampicillin was ineffective
in only 4 of 61 cases. In each of these 4 cases, the
bacterial resistance to ampicillin was noninduced.
The isolates were 1) [3-1actamase-producing Haemo-
philus influenzae, 2) K. pneumoniae, 3) resistant E. coli,
and 4) Enterobacter cloacae.
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Drug chemoprophylaxis with ampicillin alters the
incidence of disease by diminishing the denominator,
thus magnifying the impact of the numerator. As a
consequence, the perception of the relative impor-
tance ofan isolate is changed. In the setting described
by McDuffie et al., ampicillin did not select a resis-
tant organism to produce disease, but merely altered
the proportionality of resistant to nonresistant isolates
within the equation. McDuffie et al. identified 4
cases in the numerator without regard to impact of
drugs on the denominator. The report failed to iden-
tify the time frame over which these cases were col-
lected, the projected number ofcases ofchorioamnio-
nitis or perinatal septicemia which would have been
successfully treated or aborted by ampicillin, or the
presence or absence of asymptomatic bacteriemia.
So What?
Why is there the need to clarify conceptual thought?
Once an idea is published without challenge, it has
potential to take on a life of its own. In 1994 and
1996, the Centers of Disease Control3,4 published in
the Federal Register their preliminary proposal for ad-
dressing the eradication or reduction of early-onset
group-B streptococcal neonatal disease. In the Execu-
tive Summary of the committee’s recommendations
for limiting the use of intrapartum chemoprophylaxis
is the following statement (citing McDuffie et al.3):
"... limit the use of antimicrobials to about 5% of all
deliveries, thus minimizing maternal side effects and
the emergence of antimicrobial-resistant organisms."
Good intentions may become dangerous due to
conceptual errors.
Gilles R.G. Monif
Department of Obstetrics and Gynecology
Creighton University School ofMedicine
Omaha, Nebraska
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